CA2291608C - Neurotrophic factor receptors - Google Patents
Neurotrophic factor receptors Download PDFInfo
- Publication number
- CA2291608C CA2291608C CA002291608A CA2291608A CA2291608C CA 2291608 C CA2291608 C CA 2291608C CA 002291608 A CA002291608 A CA 002291608A CA 2291608 A CA2291608 A CA 2291608A CA 2291608 C CA2291608 C CA 2291608C
- Authority
- CA
- Canada
- Prior art keywords
- gdnfr
- amino acid
- gdnf
- acid sequence
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/866,354 | 1997-05-30 | ||
US08/866,354 US7138251B1 (en) | 1996-04-22 | 1997-05-30 | Polynucleotides encoding a neurotrophic factor receptor |
PCT/US1998/008486 WO1998054213A2 (en) | 1997-05-30 | 1998-04-27 | Neurotrophic factor receptors |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2291608A1 CA2291608A1 (en) | 1998-12-03 |
CA2291608C true CA2291608C (en) | 2004-04-13 |
Family
ID=25347430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002291608A Expired - Lifetime CA2291608C (en) | 1997-05-30 | 1998-04-27 | Neurotrophic factor receptors |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0983354A2 (de) |
JP (1) | JP2002505576A (de) |
AU (1) | AU7165998A (de) |
CA (1) | CA2291608C (de) |
WO (1) | WO1998054213A2 (de) |
ZA (1) | ZA984404B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6696259B1 (en) | 1995-11-13 | 2004-02-24 | Licentia Ltd. | Assays using glial cell line-derived neurotrophic factor receptors |
US6677135B1 (en) | 1996-05-08 | 2004-01-13 | Biogen, Inc. | Ret ligand (RetL) for stimulating neutral and renal growth |
KR20010012826A (ko) * | 1997-05-22 | 2001-02-26 | 세파론, 인코포레이티드 | 신경교 세포주-유래 향신경성 인자 수용체 |
DK1064376T3 (da) * | 1998-03-23 | 2006-07-24 | Genentech Inc | GFR-alpha3 og dets anvendelser |
US7026138B1 (en) | 1998-03-23 | 2006-04-11 | Genentech, Inc. | Polynucleotides encoding GFRα3 |
DE19816186A1 (de) * | 1998-04-14 | 1999-10-21 | Univ Muenchen L Maximilians | GDNF-kodierende DNA, Teile davon und GDNF-Varianten |
EP3538560A4 (de) | 2016-11-10 | 2020-06-17 | Keros Therapeutics, Inc. | Gdnf-fusionspolypeptide und verfahren zur verwendung davon |
JP2022547305A (ja) * | 2019-09-13 | 2022-11-11 | ラトガース,ザ ステート ユニバーシティ オブ ニュー ジャージー | Aav適合性ラミニン-リンカー重合タンパク質 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4006054A1 (de) * | 1990-02-26 | 1991-08-29 | Boehringer Mannheim Gmbh | Verfahren zur immunologischen bestimmung von liganden |
WO1995005452A2 (en) * | 1993-08-12 | 1995-02-23 | Cytotherapeutics, Inc. | Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
US6455277B1 (en) * | 1996-04-22 | 2002-09-24 | Amgen Inc. | Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides |
CN1163509C (zh) * | 1996-05-08 | 2004-08-25 | 拜奥根有限公司 | 刺激神经和肾生长的RET配体(RetL) |
EP0846764A3 (de) * | 1996-11-27 | 1998-09-30 | Smithkline Beecham Plc | Gliale neurotrophe Faktoren alpha Rezeptorfamilie |
ES2258295T3 (es) * | 1997-02-18 | 2006-08-16 | Genentech, Inc. | Receptor de la neurturina. |
-
1998
- 1998-04-27 JP JP50067499A patent/JP2002505576A/ja not_active Ceased
- 1998-04-27 EP EP98918805A patent/EP0983354A2/de not_active Withdrawn
- 1998-04-27 WO PCT/US1998/008486 patent/WO1998054213A2/en active Application Filing
- 1998-04-27 AU AU71659/98A patent/AU7165998A/en not_active Abandoned
- 1998-04-27 CA CA002291608A patent/CA2291608C/en not_active Expired - Lifetime
- 1998-05-25 ZA ZA984404A patent/ZA984404B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA984404B (en) | 1998-12-01 |
CA2291608A1 (en) | 1998-12-03 |
EP0983354A2 (de) | 2000-03-08 |
WO1998054213A3 (en) | 1999-01-07 |
JP2002505576A (ja) | 2002-02-19 |
AU7165998A (en) | 1998-12-30 |
WO1998054213A2 (en) | 1998-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060166325A1 (en) | Glial cell line-derived neurotrophic factor receptor | |
JP4909843B2 (ja) | 截形グリア細胞系由来神経栄養因子 | |
AU1352497A (en) | Novel tyrosine kinase receptors and ligands | |
WO2000034475A9 (en) | Grnf4, a gdnf-related neurotrophic factor | |
CA2291608C (en) | Neurotrophic factor receptors | |
US6413740B1 (en) | Tyrosine kinase receptors and ligands | |
US7138251B1 (en) | Polynucleotides encoding a neurotrophic factor receptor | |
KR100399377B1 (ko) | Gdnf 단백질의 분석방법 및 검정 기구 | |
TW509696B (en) | Glial cell line-derived neurotrophic factor receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |